PTC Therapeutics
PTCT
#3034
Rank
S$6.83 B
Marketcap
S$81.81
Share price
0.21%
Change (1 day)
-16.65%
Change (1 year)

P/S ratio for PTC Therapeutics (PTCT)

P/S ratio as of November 2026 (TTM): 4.59

According to PTC Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -32.1. At the end of 2026 the company had a P/S ratio of 4.58.

P/S ratio history for PTC Therapeutics from 2013 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.5828.74%
20253.56-17.66%
20244.3294.97%
20232.22-44.37%
20223.99-23.76%
20215.23-52.2%
202010.912.86%
20199.6947.71%
20186.5684.28%
20173.56-21.36%
20164.53-83.83%
201528.0-62.25%
201474.2475.16%
201312.9

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
5.28 15.12%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
10.5 129.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
13.9 202.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
0.8728-80.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
24.0 422.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
600 12,966.86%๐Ÿ‡บ๐Ÿ‡ธ USA